Showing results (41-50 of 183) with videos related to

Sort By:
Pageof 19
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 20, 2020
A survey on clinical pathways of patients with epilepsy and cerebrovascular diseases or brain tumorsGaetano Zaccara, Vincenzo Esposito, Marta Maschio, et al.
Epilepsia|September 16, 2025
Early seizure freedom with [18F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case reportRoberta Rudà, Francesco Bruno, Alessia Pellerino, et al.
International Journal of Molecular Sciences|November 17, 2020
Management of Brain and Leptomeningeal Metastases from Breast CancerAlessia Pellerino, Valeria Internò, Francesca Mo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 22, 2015
Molecularly based management of gliomas in clinical practiceRoberta Rudà, Alessia Pellerino, Michela Magistrello, et al.
Nature Reviews. Neurology|May 17, 2024
IDH inhibition in gliomas: from preclinical models to clinical trialsRoberta Rudà, Craig Horbinski, Martin van den Bent, et al.
Neuro-Oncology Practice|January 8, 2025
Financial challenges of being on long-term, high-cost medicationsCleopatra Elshiekh, Roberta Rudà, Edward R Scheffer Cliff, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 21, 2014
Antiangiogenic therapy of brain tumors: the role of bevacizumabElisa Trevisan, Luca Bertero, Chiara Bosa, et al.
Cancers|February 25, 2023
Rare Neuronal, Glial and Glioneuronal Tumours in AdultsNicolas Crainic, Julia Furtner, Johan Pallud, et al.
Cancer|February 11, 2004
Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II studyRiccardo Soffietti, Mauro Nobile, Roberta Rudà, et al.
Neuro-Oncology|February 4, 2015
Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholdsEleonora Duregon, Adele Cassenti, Alessandra Pittaro, et al.
Pageof 19